Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Trial of Impact of Crime Group Intervention for Jail Inmates (IOC-1)

3. mai 2013 oppdatert av: June Tangney, George Mason University
This pilot study is designed to evaluate the efficacy of the Impact of Crime (IOC) group intervention for jail inmates. The hypothesis is that participants in IOC will show decreases in criminogenic thinking, decreases in shame, increases in guilt, and increases in empathy, which in turn will be reflected in reduced recidivism (official records and self report), relative to those randomly assigned to a treatment as usual group.

Studieoversikt

Status

Ukjent

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

51

Fase

  • Fase 2
  • Fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • Virginia
      • Fairfax, Virginia, Forente stater, 22030
        • Fairfax County Adult Detention Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Behandling som vanlig
Atferdsmessig: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week
Eksperimentell: Impact of Crime group intervention
Atferdsmessig: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Self reported recidivism (arrests and undetected offenses)
Tidsramme: 1 year post-release up to 2 yrs post release
1 year post-release up to 2 yrs post release
Self reported recidivism (arrests and undetected offenses)
Tidsramme: 4 years post-release up to 5 yrs post release
4 years post-release up to 5 yrs post release
Self reported recidivism (arrests and undetected offenses)
Tidsramme: 7 years post-release up to 8 yrs post-release
7 years post-release up to 8 yrs post-release
Self reported recidivism (arrests and undetected offenses)
Tidsramme: 10 years post-release up to 11 yrs post-release
10 years post-release up to 11 yrs post-release
Self-reported Substance Use and Dependence - TCU
Tidsramme: 1 year post-release up to 2 yrs post-release
1 year post-release up to 2 yrs post-release
Self-reported Substance Use and Dependence - TCU
Tidsramme: 4 years post-release up to 5 yrs post-release
4 years post-release up to 5 yrs post-release
Self-reported Substance Use and Dependence - TCU
Tidsramme: 7 years post-release up to 8 yrs post-release
7 years post-release up to 8 yrs post-release
Self-reported Substance Use and Dependence - TCU
Tidsramme: 10 years post-release up to 11 yrs post release
10 years post-release up to 11 yrs post release
Self-reported HIV risk behaviors (sex and IDU) - TCU
Tidsramme: 1 year post-release - up to 2 yrs post-release
1 year post-release - up to 2 yrs post-release
Self-reported HIV risk behaviors (sex and IDU) - TCU
Tidsramme: 4 years post-release up to 5 yrs post-release
4 years post-release up to 5 yrs post-release
Self-reported HIV risk behaviors (sex and IDU) - TCU
Tidsramme: 7 years post-release up to 8 yrs post-release
7 years post-release up to 8 yrs post-release
Self-reported HIV risk behaviors (sex and IDU) - TCU
Tidsramme: 10 years post-release up to 11 yrs post-release
10 years post-release up to 11 yrs post-release

Sekundære resultatmål

Resultatmål
Tidsramme
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to post-treatment up to 9 mos
Baseline to post-treatment up to 9 mos
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to pre-release up to 1.5 yrs
Baseline to pre-release up to 1.5 yrs
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to 1 yr post-release up to 3.5 yrs
Baseline to 1 yr post-release up to 3.5 yrs
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to 4 yrs post-release up to 6.5 yrs
Baseline to 4 yrs post-release up to 6.5 yrs
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to 7 yrs post-release up 9,5 yrs
Baseline to 7 yrs post-release up 9,5 yrs
Changes from baseline in Self reported criminogenic beliefs - CCS
Tidsramme: Baseline to 10 yrs post-release up to 12.5 yrs
Baseline to 10 yrs post-release up to 12.5 yrs
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to post-treatment up to 9 mos
Baseline to post-treatment up to 9 mos
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to pre-release up to 1.5 yrs
Baseline to pre-release up to 1.5 yrs
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to 1 yr post release up to 3.5 yrs
Baseline to 1 yr post release up to 3.5 yrs
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to 4 yrs post release up to 6.5 yrs
Baseline to 4 yrs post release up to 6.5 yrs
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to 7 yrs post release up to 9.5 yrs
Baseline to 7 yrs post release up to 9.5 yrs
Changes from baseline in self-reported shame - TOSCA-SD
Tidsramme: Baseline to 10 yrs post release up to 12.5 yrs
Baseline to 10 yrs post release up to 12.5 yrs
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to post-treatment up to 9 mos
Baseline to post-treatment up to 9 mos
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to pre-release up to 1.5 yrs
Baseline to pre-release up to 1.5 yrs
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to 1 yr post-release up to 3.5 yrs
Baseline to 1 yr post-release up to 3.5 yrs
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to 4 yrs post-release up to 6.5 yrs
Baseline to 4 yrs post-release up to 6.5 yrs
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to 7 yrs post-release up to 9.5 yrs
Baseline to 7 yrs post-release up to 9.5 yrs
Changes from baseline in self-reported Guilt - TOSCA-SD
Tidsramme: Baseline to 10 yrs post-release up to 12.5 yrs
Baseline to 10 yrs post-release up to 12.5 yrs
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to post-treatment up to 9 mos
Baseline to post-treatment up to 9 mos
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to pre-release up to 1.5 yrs
Baseline to pre-release up to 1.5 yrs
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to 1 year post-release up to 3.5 yrs
Baseline to 1 year post-release up to 3.5 yrs
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to 4 years post-release up to 6.5 yrs
Baseline to 4 years post-release up to 6.5 yrs
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to 7 years post-release up to 9.5 yrs
Baseline to 7 years post-release up to 9.5 yrs
Changes from baseline in self-reported Empathy - IRI
Tidsramme: Baseline to 10 years post-release up to 12.5 yrs
Baseline to 10 years post-release up to 12.5 yrs

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

George Mason University

Samarbeidspartnere

National Institute on Drug Abuse (NIDA)

Etterforskere

  • Hovedetterforsker: June P Tangney, Ph.D., George Mason University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. august 2002

Primær fullføring (Forventet)

1. august 2013

Studiet fullført (Forventet)

1. juli 2016

Datoer for studieregistrering

Først innsendt

21. juni 2011

Først innsendt som oppfylte QC-kriteriene

23. juni 2011

Først lagt ut (Anslag)

27. juni 2011

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

7. mai 2013

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. mai 2013

Sist bekreftet

1. mai 2013

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • R01DA014694-1
  • R01DA014694 (U.S. NIH-stipend/kontrakt)

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Impact of Crime group intervention

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Gambia

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

3
Abonnere